Food & Drug Law

Mason Marks & I. Glenn Cohen, Patents on Psychedelics: The Next Legal Battlefront of Drug Development, 135 Harv. L. Rev. F. (2022).

Kerry Lynn Macintosh, I. Glenn Cohen, Jacob. S. Sherkow & Eli Y. Adashi, Gene Editing Sperm and Eggs for Use in Clinical Trials – The…

Patricia J. Zettler, Eli Y. Adashi & I. Glenn Cohen, A Divisive Ruling on Devices – Genus Medical Technologies v. FDA, 385 New England J.

Eli Y. Adashi & I. Glenn Cohen, When Failure Is Not an Option: The Independent Panel Pandemic Report, Am. J. Med. (2021).

Eli Y. Adashi, Rohit S. Rajan & I. Glenn Cohen, When Science and Politics Collide: Enhancing the FDA, 364 Science 628 (2019).

Craig M. Klugman, Laura B. Dunn, Jack Schwartz & I. Glenn Cohen, Response to Open Peer Commentaries on “The Ethics of Smart Pills and Self-Acting…

I. Glenn Cohen & Alex Pearlman, Every Pill You Take, New Scientist, Sept. 29, 2018, at 22.

Craig M. Klugman, Laura B. Dunn, Jack Schwartz & I. Glenn Cohen, The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at…

Spencer Phillips Hey, I. Glenn Cohen, Eli Y. Adashi & Aaron S. Kesselheim, Influence, Integrity, and the FDA: An Ethical Framework, 357 Science 876 (2017).

Nathan G. Cortez, I. Glenn Cohen & Aaron S. Kesselheim, FDA Regulation of Mobile Health Technologies, 370 New Eng. J. Med. 372 (2014).

I. Glenn Cohen & Eli Y. Adashi, The FDA is Prohibited From Going Germline, 353 Science 545 (2016).

Michelle M. Mello & I. Glenn Cohen, Clinical Trials and the Right to Remain Silent, 174 JAMA Internal Med. 1505 (2014).

I. Glenn Cohen, Jeremy Feigenbaum & Eli Y. Adashi, Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men, 312…

Andrew English, David Rosenberg & Huaou Yan, A New Regulatory Function for E-Prescriptions: Linking the FDA to Physicians and Patient Records (Harv. L. Sch. Pub.

Peter Grossi & Keri Arnold, Drug Product Liability at the Crossroads, in The Oxford Handbook of U.S. Health Law (I. Glenn Cohen, Allison K. Hoffman…

Peter Grossi & Daphne O’Connor, FDA preemption of conflicting state drug regulation and the looming battle over abortion medications, 10 J. L. Biosciences (2023).

I. Glenn Cohen & Nicholas Bagley, Private Rights and the Public Interest in Drug and Medical Device Litigation, 180 JAMA Internal Med. 299 (2019).

Sara Gerke, Timo Minssen, Helen Yu & I. Glenn Cohen, Ethical and Legal Issues of Ingestible Electronic Sensors, 2 Nature Electronics 329 (2019).

I. Glenn Cohen & Shelly Simana, Regulation of Stem Cell Therapy Travel, 4 Current Stem Cell Rep. 220 (2018).

Brian Wolfman & Anne King, Mutual Pharmaceutical Co. v. Bartlett and Its Implications, 82 U.S.L.W., no. 17, at 1 (Nov. 5, 2013).

Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, State Legal Initiatives to Restrict and Protect Mifepristone Access, 107 R.I. Med. J. 44 (2024).